Another Case of Bell's Palsy Recurrence After Pfizer-BioNTech COVID-19 Vaccination

Huailin Zhang1, Diana Sanchez Gomez2, Michael Repajic3

  • 1Internal Medicine, Adventist Health White Memorial, Los Angeles, USA.

Cureus
|August 1, 2022
PubMed

Insights

Limited data exist on recurrent Bell's Palsy following mRNA vaccines. Continued rigorous reporting is essential to accurately determine the incidence of this rare neurological condition after vaccination.

Area of Science:

  • Neurology
  • Vaccinology
  • Epidemiology

Background:

  • The COVID-19 pandemic necessitated rapid vaccine development, including mRNA-based vaccines.
  • Bell's Palsy, a form of facial paralysis, has been an observed, though rare, adverse event post-vaccination.
  • Data on the recurrence of Bell's Palsy after mRNA vaccination remain scarce.